Prime Medicine, Inc. (PRME)
NASDAQ·Healthcare·Biotechnology
$3.70
+0.82%
Mkt Cap $668.04M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (4 analysts)
$17.25
Range $12.00 – $23.00
Implied Upside
+366.2%
Consensus $17.25 vs current $3.70
NASDAQ·Healthcare·Biotechnology
$3.70
+0.82%
Mkt Cap $668.04M
Buy
1
Hold
1
Sell
0
Price Target (4 analysts)
$17.25
Range $12.00 – $23.00
+366.2%
Consensus $17.25 vs current $3.70